oseltamivir has been researched along with Innate Inflammatory Response in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 3 (30.00) | 2.80 |
Authors | Studies |
---|---|
Al Rumaih, Z; Chaudhri, G; Karupiah, G; Kc, R; Kels, MJT; Malley, R; Ng, E; Pandey, P | 1 |
Bai, Q; Fei, GH; Ji, S; Shen, JL; Wang, S; Wu, X; Zhang, DW | 1 |
Hensen, L; Hurt, AC; Kedzierska, K; Kedzierski, L; Koutsakos, M; Mercuri, F; Mifsud, E; Nüssing, S; Rossignol, JF; Wang, Z | 1 |
Hoshino, K; Kubo, S; Tomozawa, T; Yamashita, M | 1 |
Covello, LHS; Da Silva Teixeira, RER; de Godoy, LG; de Oliveira, NE; Dutra, KR; Frini, ICM; Furlan, NP; Gandolfi, JV; Lobo, SM; Nogueira, ML; Queiroz, F; Sacillotto, GH; Salomão, MLM; Simões, ES; Watanabe, ASA | 1 |
Abdulkhalek, S; Szewczuk, MR | 1 |
Bird, NL; Chua, BY; Handel, A; Hurt, AC; Jackson, DC; Kedzierska, K; Oh, DY; Olson, MR; Oshansky, CM; Reading, PC; Sun, Y; Tang, L; Thomas, PG; Turner, SJ | 1 |
Chang, SY; Hong, EH; Jeong, HG; Kim, H; Kim, JG; Kim, YJ; Ko, HJ; Kwon, BE; Kwon, Y; Lee, BR; Seo, SU; Shim, A; Song, HH; Song, JH | 1 |
Kobayashi, D; Kuramochi, M; Nemoto, E; Oshima, S; Saitoh, Y | 1 |
Carr, JA; Hayden, FG; Ives, JA; Kelly, L; Lambkin, R; Mendel, DB; Oxford, JS; Roberts, NA; Tai, CY | 1 |
10 other study(ies) available for oseltamivir and Innate Inflammatory Response
Article | Year |
---|---|
Therapeutic Targeting of Inflammation and Virus Simultaneously Ameliorates Influenza Pneumonia and Protects from Morbidity and Mortality.
Topics: Animals; Antiviral Agents; COVID-19; Cytokines; Etanercept; Humans; Inflammation; Influenza A virus; Influenza, Human; Mice; Morbidity; Oseltamivir; Pneumonia; SARS-CoV-2 | 2023 |
Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.
Topics: Acute Lung Injury; Animals; Antiviral Agents; Bronchi; Bronchoalveolar Lavage Fluid; Cell Line; Coculture Techniques; Drugs, Chinese Herbal; Epithelial Cells; Humans; Inflammasomes; Inflammation; Influenza A virus; Influenza, Human; Interleukin-18; Interleukin-1beta; Lung; Male; Orthomyxoviridae Infections; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Viral Load | 2020 |
Viral burden, inflammatory milieu and CD8
Topics: Animals; Antiviral Agents; Bronchoalveolar Lavage Fluid; CD8-Positive T-Lymphocytes; Cytokines; Inflammation; Influenza A virus; Killer Cells, Natural; Lung; Mice; Neutrophils; Orthomyxoviridae Infections; Oseltamivir; Thiazoles; Viral Load; Weight Loss | 2020 |
Efficacy of laninamivir octanoate in mice with advanced inflammation stage caused by infection of highly lethal influenza virus.
Topics: Animals; Antiviral Agents; Cell Line; Dogs; Enzyme Inhibitors; Female; Guanidines; Inflammation; Influenza A Virus, H5N1 Subtype; Influenza A Virus, H7N9 Subtype; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred BALB C; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Pyrans; Sialic Acids; Zanamivir | 2019 |
Excess mortality is associated with influenza A (H1N1) in patients with severe acute respiratory illness.
Topics: Adult; Aged; Antiviral Agents; Female; Hospital Mortality; Humans; Inflammation; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Oseltamivir; Respiratory Distress Syndrome; Respiratory Tract Infections; Risk Factors; Time-to-Treatment | 2019 |
Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses.
Topics: Aminoquinolines; Animals; Cell Line; Endosomes; Enzyme Inhibitors; Gene Expression Regulation; HEK293 Cells; Humans; Imiquimod; Inflammation; Interferon Inducers; Macrophages; Matrix Metalloproteinase 9; Mice; Neuraminidase; NF-kappa B; Oligonucleotides; Oseltamivir; Receptors, Bombesin; RNA, Small Interfering; Signal Transduction; Toll-Like Receptor 7; Toll-Like Receptor 9 | 2013 |
Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses.
Topics: Adolescent; Adult; Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Child, Preschool; Female; Ferrets; Humans; Infant; Inflammation; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Oseltamivir; Viral Load; Young Adult | 2015 |
Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with Oseltamivir.
Topics: Animals; Antiviral Agents; Bronchoalveolar Lavage Fluid; Cytokines; Cytopathogenic Effect, Viral; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Hedera; In Vitro Techniques; Inflammation; Influenza A virus; Lung; Mice; Mice, Inbred C57BL; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Phytotherapy; Plant Extracts; Saponins | 2015 |
Penetration of oseltamivir and its active metabolite into the brain after lipopolysaccharide-induced inflammation in mice.
Topics: Animals; Antiviral Agents; Blood-Brain Barrier; Brain; Evans Blue; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Motor Activity; Oseltamivir | 2009 |
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
Topics: Acetamides; Amino Acid Substitution; Animals; Antiviral Agents; Body Weight; Cell Line; Disease Models, Animal; Drug Resistance, Viral; Ferrets; Fever; Humans; In Vitro Techniques; Inflammation; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mice; Mice, Inbred BALB C; Mutagenesis, Site-Directed; Mutation; Neuraminidase; Oseltamivir; Sequence Analysis, DNA; Virus Replication | 2002 |